News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,303 Results
Type
Article (40627)
Company Profile (258)
Press Release (661418)
Section
Business (206590)
Career Advice (2019)
Deals (35813)
Drug Delivery (93)
Drug Development (81204)
Employer Resources (169)
FDA (16334)
Job Trends (14956)
News (348507)
Policy (32797)
Tag
Academia (2580)
Alliances (50234)
Alzheimer's disease (1335)
Approvals (16319)
Artificial intelligence (217)
Bankruptcy (361)
Best Places to Work (11704)
Biotechnology (178)
Breast cancer (232)
Cancer (1773)
Cardiovascular disease (132)
Career advice (1683)
CAR-T (128)
Cell therapy (368)
Clinical research (65490)
Collaboration (688)
Compensation (379)
COVID-19 (2594)
C-suite (174)
Data (1686)
Diabetes (221)
Diagnostics (6685)
Earnings (86416)
Employer resources (145)
Events (112345)
Executive appointments (589)
FDA (17278)
Funding (623)
Gene therapy (253)
GLP-1 (658)
Government (4406)
Healthcare (18979)
Infectious disease (2712)
Interviews (314)
IPO (16621)
Job creations (3688)
Job search strategy (1434)
Layoffs (443)
Legal (7942)
Lung cancer (259)
Manufacturing (242)
Medical device (13422)
Medtech (13427)
Mergers & acquisitions (19580)
Metabolic disorders (570)
Neuroscience (1754)
NextGen: Class of 2025 (6554)
Non-profit (4532)
Northern California (2176)
Obesity (313)
Opinion (197)
Patents (173)
People (57557)
Phase I (20393)
Phase II (28861)
Phase III (21469)
Pipeline (773)
Postmarket research (2566)
Preclinical (8618)
Radiopharmaceuticals (249)
Rare diseases (331)
Real estate (5990)
Regulatory (22202)
Research institute (2355)
Resumes & cover letters (351)
Southern California (1879)
Startups (3650)
United States (19233)
Vaccines (620)
Weight loss (213)
Date
Today (32)
Last 7 days (808)
Last 30 days (2639)
Last 365 days (34541)
2025 (5309)
2024 (35519)
2023 (40432)
2022 (51549)
2021 (56105)
2020 (54582)
2019 (46972)
2018 (35404)
2017 (32524)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26920)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (733)
Arizona (213)
Asia (38316)
Australia (6285)
California (4977)
Canada (1752)
China (411)
Colorado (226)
Connecticut (235)
Europe (82803)
Florida (729)
Georgia (177)
Illinois (468)
Indiana (270)
Japan (126)
Maryland (762)
Massachusetts (3775)
Michigan (200)
Minnesota (350)
New Jersey (1403)
New York (1424)
North Carolina (889)
Northern California (2176)
Ohio (175)
Pennsylvania (1127)
South America (1111)
Southern California (1879)
Texas (730)
Utah (154)
Washington State (484)
702,303 Results for "exagen diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Exagen Inc. to Participate in Upcoming Investor Conferences - February 4, 2025
February 5, 2025
·
1 min read
Press Releases
Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025
February 25, 2025
·
1 min read
Press Releases
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 14, 2024
·
1 min read
Press Releases
Exagen Inc. Reports Third Quarter 2024 Results
November 13, 2024
·
12 min read
Business
Exagen Inc. Announces Changes to the Board of Directors
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors.
April 26, 2024
·
4 min read
Press Releases
Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
January 13, 2025
·
9 min read
Biotech Beach
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 13-14, 2024 in Snowbird, Utah.
January 30, 2024
·
1 min read
Business
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
Exagen Inc., a leading provider of autoimmune testing solutions, reported financial results for the quarter ended March 31, 2024.
May 13, 2024
·
10 min read
Press Releases
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
November 14, 2024
·
5 min read
Business
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
Exagen Inc. today reported financial results for the fourth quarter and full year ended December 31, 2023.
March 18, 2024
·
11 min read
1 of 70,231
Next
